moxifloxacin has been researched along with Aneurysm, Aortic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohgu, S; Inada, K; Koga, M; Yamada, A; Yamauchi, A | 1 |
| Bennett, AC; Bennett, CL; Witherspoon, BJ | 1 |
| Frassineti, GL; Monti, M; Ruscelli, S; Silimbani, P | 1 |
3 other study(ies) available for moxifloxacin and Aneurysm, Aortic
| Article | Year |
|---|---|
Moxifloxacin induces aortic aneurysm and dissection by increasing osteopontin in mice.
Topics: Angiotensin II; Animals; Anti-Bacterial Agents; Aortic Aneurysm; Aortic Dissection; Disease Models, Animal; Elastin; Eosine Yellowish-(YS); Hematoxylin; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Moxifloxacin; Muscle Proteins; Myocytes, Smooth Muscle; Osteopontin; Rubber; Water | 2022 |
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and dru
Topics: Animals; Aortic Aneurysm; Ciprofloxacin; Dissection; Humans; Idiopathic Pulmonary Fibrosis; Levofloxacin; Moxifloxacin; United States; United States Food and Drug Administration | 2020 |
Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administra
Topics: Aortic Aneurysm; Ciprofloxacin; Dissection; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; United States; United States Food and Drug Administration | 2020 |